NLRX1 antibody (AA 45-205) (HRP)
Quick Overview for NLRX1 antibody (AA 45-205) (HRP) (ABIN7161658)
Target
See all NLRX1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 45-205
-
Cross-Reactivity
- Human
-
Purification
- >95%, Protein G purified
-
Immunogen
- Recombinant Human NLR family member X1 protein (45-205AA)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- NLRX1 (NLR Family Member X1 (NLRX1))
-
Alternative Name
- NLRX1
-
Background
-
Background: Participates in antiviral signaling. Acts as a negative regulator of MAVS-mediated antiviral responses, through the inhibition of the virus-induced RLH (RIG-like helicase)-MAVS interaction (PubMed:18200010). Has no inhibitory function on NF-Kappa-B and type 1 interferon signaling pathways, but enhances NF-Kappa-B and JUN N-terminal kinase dependent signaling through the production of reactive oxygen species (PubMed:18219313).
Aliases: Caterpiller protein 11.3 antibody, CLR11.3 antibody, DLNB26 antibody, FLJ21478 antibody, MGC131937 antibody, MGC21025 antibody, NLR family member X1 antibody, NLR family, X1 antibody, Nlrx1 antibody, NLRX1_HUMAN antibody, NOD-like receptor X1 antibody, NOD26 antibody, NOD5 antibody, NOD9 antibody, Nucleotide-binding oligomerization domain protein 26 antibody, Nucleotide-binding oligomerization domain protein 5 antibody, Nucleotide-binding oligomerization domain protein 9 antibody, nucleotide-binding oligomerization domain, leucine rich repeat containing X1 antibody, Protein Caterpiller 11.3 antibody
-
UniProt
- Q86UT6
-
Pathways
- SARS-CoV-2 Protein Interactome
Target
-